Caris Life Sciences (CAI) Return on Sales (2024 - 2026)

Caris Life Sciences' Return on Sales history runs 3 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Sales rose 1.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (up 1.0% YoY), while the FY2025 annual figure was 0.0%, up 1.0% from the prior year.
• Return on Sales was 0.0% for Q1 2026 at Caris Life Sciences, down from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2025 to a low of 0.01% in Q1 2025.
• Historically, Return on Sales has averaged 0.0% across 3 years, with a median of 0.0% in 2024.
• Biggest YoY gain for Return on Sales was 1 bps in 2025; the steepest drop was 0 bps in 2025.
• A 3-year view of Return on Sales shows it stood at 0.0% in 2024, then jumped by 198 bps to 0.0% in 2025, then tumbled by 101 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.